bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

bioAffinity Technologies will present at the American Society for Cell Biology (ASCB) Conference on December 3-7 2022

by Maria Zannes | Dec 1, 2022 | Events

December 1, 2022 bioAffinity Technologies will present at at Cell Bio during the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) Conference bioAffinity reports on a potential therapeutic approach that kills cancer cells...

bioAffinity Technologies will exhibit at the MEGA Lung event as part of the UTSA Health Fair on November 17, 2022

by Maria Zannes | Nov 15, 2022 | Events

November 17, 2022 bioAffinity Technologies will exhibit at the MEGA Lung event as part of the UTSA Health Fair on November 17, 2022.

bioAffinity Technologies will be at the CHEST Conference to Present Results from “Flow Cytometry Analysis of the Lung”

by Maria Zannes | Oct 14, 2022 | Events

October 19, 2022 bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference Powerful platform reveals the lung environment for diagnosing lung diseases Research Scientist Lydia Bederka, PhD, will present results of the...

bioAffinity Technologies Presents its CyPath® Lung test and Exhibits at the National Association of Veterans’ Research and Education Foundation (NAVREF)

by Maria Zannes | Sep 9, 2022 | Events

September 11-14, 2022 bioAffinity Technologies Presents its CyPath® Lung test and Exhibits at the National Association of Veterans’ Research and Education Foundation (NAVREF) President and Chief Executive Officer Maria Zannes will speak about bioAffinity Technologies...

bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry

by Maria Zannes | Jul 19, 2022 | Events

July 21, 2022 bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry Senior Vice President William Bauta, Ph.D., will present research leading to development of a product for use with flow cytometry, including its use...

bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection

by Maria Zannes | Apr 25, 2022 | Events

April 28, 2022 bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection Chief Medical and Science Officer and Executive Vice President Vivienne Rebel, MD, PhD, will present at the Cleveland...
« Older Entries
Next Entries »

Categories

  • Articles (29)
  • Events (38)
  • News (54)
  • Press Releases (165)
  • Publications (19)

Recent Posts

  • bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment April 28, 2026
  • New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy April 14, 2026
  • bioAffinity Technologies’ CyPath® Lung to be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 April 7, 2026
  • bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 April 1, 2026
  • bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice March 25, 2026
CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.